National Research Corp (NRC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, National Research Corp (NRC) has a cash flow conversion efficiency ratio of 0.532x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.18 Million) by net assets ($13.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NRC net asset quality score to measure how much of total assets are equity-financed.
National Research Corp - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how National Research Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check National Research Corp earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
National Research Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of National Research Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Morguard North American Residential Real Estate Investment Trust
TO:MRG-UN
|
0.008x |
|
Diageo PLC
LSE:DGE
|
0.082x |
|
Zhejiang Sunrise Garment Group Co Ltd
SHG:605138
|
N/A |
|
Optotech Corp
TW:2340
|
-0.010x |
|
Norma Group AG NA O.N.
XETRA:NOEJ
|
0.035x |
|
Zhejiang Guangsha Co Ltd
SHG:600052
|
0.029x |
|
Pacific Biosciences of California
NASDAQ:PACB
|
-18.889x |
|
IGG Inc
F:I91
|
-0.006x |
Annual Cash Flow Conversion Efficiency for National Research Corp (1996–2025)
The table below shows the annual cash flow conversion efficiency of National Research Corp from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see how much is National Research Corp worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $13.99 Million | $26.45 Million | 1.891x | +70.82% |
| 2024-12-31 | $31.28 Million | $34.62 Million | 1.107x | +42.16% |
| 2023-12-31 | $48.95 Million | $38.11 Million | 0.779x | +54.64% |
| 2022-12-31 | $72.03 Million | $36.27 Million | 0.503x | -7.30% |
| 2021-12-31 | $85.34 Million | $46.34 Million | 0.543x | -14.05% |
| 2020-12-31 | $64.31 Million | $40.64 Million | 0.632x | -49.21% |
| 2019-12-31 | $32.89 Million | $40.92 Million | 1.244x | -40.43% |
| 2018-12-31 | $19.08 Million | $39.85 Million | 2.088x | +569.32% |
| 2017-12-31 | $90.04 Million | $28.09 Million | 0.312x | -3.76% |
| 2016-12-31 | $82.81 Million | $26.84 Million | 0.324x | +9.93% |
| 2015-12-31 | $74.22 Million | $21.89 Million | 0.295x | -1.23% |
| 2014-12-31 | $87.75 Million | $26.20 Million | 0.299x | +10.91% |
| 2013-12-31 | $71.75 Million | $19.32 Million | 0.269x | -20.17% |
| 2012-12-31 | $56.74 Million | $19.13 Million | 0.337x | +1.36% |
| 2011-12-31 | $55.55 Million | $18.48 Million | 0.333x | +10.68% |
| 2010-12-31 | $48.58 Million | $14.60 Million | 0.301x | -2.85% |
| 2009-12-31 | $44.17 Million | $13.67 Million | 0.309x | -21.31% |
| 2008-12-31 | $38.60 Million | $15.18 Million | 0.393x | +14.14% |
| 2007-12-31 | $42.29 Million | $14.57 Million | 0.344x | +85.83% |
| 2006-12-31 | $36.75 Million | $6.81 Million | 0.185x | -26.21% |
| 2005-12-31 | $32.59 Million | $8.19 Million | 0.251x | +12.54% |
| 2004-12-31 | $35.02 Million | $7.82 Million | 0.223x | -12.43% |
| 2003-12-31 | $32.42 Million | $8.27 Million | 0.255x | +66.71% |
| 2002-12-31 | $28.02 Million | $4.28 Million | 0.153x | +15.95% |
| 2001-12-31 | $23.35 Million | $3.08 Million | 0.132x | +39.36% |
| 2000-12-31 | $21.38 Million | $2.02 Million | 0.095x | -49.71% |
| 1999-12-31 | $18.60 Million | $3.50 Million | 0.188x | -18.15% |
| 1998-12-31 | $17.40 Million | $4.00 Million | 0.230x | +177.39% |
| 1997-12-31 | $18.10 Million | $1.50 Million | 0.083x | -97.24% |
| 1996-12-31 | $2.10 Million | $6.30 Million | 3.000x | -- |
About National Research Corp
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, an… Read more